How to distinguish mpox from its mimickers: An observational retrospective cohort study
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29147 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Coline Mortier und 14 weiteren Autor:innen. Beteiligte Einrichtung: IHU Méditerranée Infection, Marseille, France. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Chickenpox, Cross Infection, Orthopoxvirus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
During the current global outbreak of mpox (formerly monkeypox), atypical features were frequently described outside endemic areas, raising concerns around differential diagnosis. In this study, we included 372 adult patients who had clinical signs consistent with mpox and who were screened using non‐variola orthopoxvirus specific quantitative polymerase chain reaction (PCR) between 15 May and 15 November 2022 at the University Hospital Institute Méditerranée Infection, Marseille, France. At least one clinical sample was positive for 143 (38.4%) of these patients and 229 (61.6%) were negative. Clinically, patients who had mpox presented more frequently with systemic signs (69.9% vs. 31.0%, p < 10 −6 ) including fever (51.0% vs. 30.1%, p < 10 −3 ), myalgia (33.5% vs. 17.9%, p = 0.002), and lymphadenopathy (38.5% vs. 13.1%, p < 10 −6 ). Among the patients who were negative for the non‐variola orthopoxvirus, an alternative diagnosis was identified in 58 of them (25.3%), including chickenpox ( n = 30, 13.1%), syphilis ( n = 9, 4%), bacterial skin infection ( n = 8, 3.5%), gonococcus ( n = 5, 2.2%), HSV infection ( n = 5, 2.2%), and histoplasmosis ( n = 1, 0.4%). Overall, in the current outbreak, we show that mpox has a poorly specific clinical presentation. This reinforces the importance of microbiological confirmation. In symptomatic patients who are negative for the monkeypox virus by PCR, a broad differential diagnosis should be maintained.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IHU Méditerranée Infection, Marseille, France.
- Assistance Publique-Hôpitaux de Marseille, Marseille, France.
- Regional Health Agency of Provence-Alpes-Côte d'Azur (ARS Paca), Marseille, France.
- Infectious Diseases Department, IRD, AP-HM, SSA, VITROME, Aix-Marseille University, Marseille, France.
- Infectious Diseases Department, IRD, AP-HM, MEPHI, Aix-Marseille University, Marseille, France.
ORCID-Profile: Philippe Colson, Bernard La Scola, Nadim Cassir
Zitieren
APA
Mortier, C., Tissot-Dupont, H., Cardona, F., Bruel, C., Lahouel, S., Lasri, H., Bendamardji, K., Boschi, C., Parola, P., Million, M., Colson, P., Brouqui, P., La Scola, B., Lagier, J. C., & Cassir, N. (2023). How to distinguish mpox from its mimickers: An observational retrospective cohort study. Journal of Medical Virology. https://doi.org/10.1002/jmv.29147
Vancouver
Mortier C, Tissot-Dupont H, Cardona F, Bruel C, Lahouel S, Lasri H, et al. How to distinguish mpox from its mimickers: An observational retrospective cohort study. Journal of Medical Virology. 2023. doi:10.1002/jmv.29147
BibTeX
@article{Mortier2023,
author = {Mortier, Coline and Tissot-Dupont, Hervé and Cardona, Florian and Bruel, Christiane and Lahouel, Salima and Lasri, Hanane and Bendamardji, Karim and Boschi, Céline and Parola, Philippe and Million, Matthieu and Colson, Philippe and Brouqui, Philippe and La Scola, Bernard and Lagier, Jean-Christophe and Cassir, Nadim},
title = {How to distinguish mpox from its mimickers: An observational retrospective cohort study},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29147}
}
EUVIMED